Roche Diagnostics offers a comprehensive menu of lung cancer diagnostic solutions. Our portfolio of IHC diagnostic assays, IHC staining products, and more, deliver the high sensitivity and specificity you need.
VENTANA prediluted, optimised reagents
Our antibodies are ready-to-use on the fully automated VENTANA BenchMark IHC/ISH staining platforms, reducing the time-to-result and resources required with manual or semi-automated solutions. VENTANA prediluted, optimised reagents consistently demonstrate better performance when compared with concentrated antibodies that require manual dilution and in-house validation.
Our portfolio of lung cancer assays can assist in the stratification of disease, including non-small cell lung carcinoma (NSCLC), neuroendocrine carcinoma and their various subtypes.